计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| R304317-5g |
5g |
现货 ![]() |
| |
| R304317-25g |
25g |
现货 ![]() |
| |
| R304317-100g |
100g |
现货 ![]() |
|
| 别名 | 雷尼替丁碱 |
|---|---|
| 英文别名 | Ranitidine base |
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | Ranitidine |
| 储存温度 | -20°C储存,充氩,干燥 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 拮抗剂 |
| 作用机制 | H 2 受体拮抗剂 |
| 产品介绍 |
Ranitidine 是一种有效的,选择性的,具有口服活性的组胺 H2 受体 (histamine H2-receptor) 拮抗剂,IC50 为 3.3 μM,可抑制胃液分泌。Ranitidine 还一种是 CYP2C19 和 CYP2C9 的弱抑制剂。 |
| 纯度 | ≥98% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | (E)-1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine |
| INCHI | 1S/C13H22N4O3S/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3/h4-5,9,14-15H,6-8,10H2,1-3H3/b13-9+ |
| InChi Key | VMXUWOKSQNHOCA-UKTHLTGXSA-N |
| Smiles | CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C |
| Isomeric SMILES | CN/C(=C\[N+](=O)[O-])/NCCSCC1=CC=C(O1)CN(C)C |
| PubChem CID | 3001055 |
| 分子量 | 314.39 |
| 溶解性 | Acetonitrile (Slightly), DMSO (Slightly), Methanol (Slightly) |
|---|---|
| 敏感性 | 对湿度敏感 |
| 沸点 | 437.1ºC |
| 熔点 | 69-70°C |
| 分子量 | 314.410 g/mol |
| XLogP3 | 0.300 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 7 |
| 可旋转键计数Rotatable Bond Count | 9 |
| 精确质量Exact Mass | 314.141 Da |
| 单同位素质量Monoisotopic Mass | 314.141 Da |
| 拓扑极表面积Topological Polar Surface Area | 112.000 Ų |
| 重原子数Heavy Atom Count | 21 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 347.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 1 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 1 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS07, GHS08 |
|---|---|
| 信号词 | 危险 |
| 危险声明 |
H315: 引起皮肤刺激 H317: 可能引起皮肤过敏反应 H319: 引起严重眼睛刺激 H334: 吸入可能引起过敏或哮喘病症状或呼吸困难 H335: 可能引起呼吸道刺激 |
| 预防措施声明 |
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P264: 处理后要彻底洗手。 P271: 仅在室外或通风良好的地方使用。 P272: 被污染的工作服不允许离开工作场所 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P284: 如果通风不良,请佩戴呼吸防护装置。 P321: 特殊处理(请参阅此标签上的...)。 P302+P352: 如皮肤沾染:用水充分清洗。 P304+P340: 如误吸入:将人转移到空气新鲜处,保持呼吸舒适体位。 P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P333+P313: 如发生皮肤刺激或皮疹:求医/就诊。 P362+P364: 脱掉沾污的衣服,清洗后方可重新使用。 P405: 密闭存放 P403+P233: 存放在通风良好的地方。保持容器密闭。 P501: 将内容物/容器处理到。。。 P264+P265: 处理后彻底洗手[和…]。不要触摸眼睛。 P337+P317: 如果眼睛刺激持续:寻求医疗帮助。 P332+P317: 如果出现皮肤刺激:请寻求医疗帮助。 P319: 如果你感到不适,请寻求医疗帮助。 P342+P316: 如果出现呼吸道症状:立即寻求急救。 |
| 1. Jianrui Niu, Hua Jia, Minghao Yu, Jinyu Zhu, Junjun Ma, Zhuang He, Weizhang Zhong, Yongjiang Hou, Yankai Guo. (2024) Nitrogen-rich penicillin residue biochar for activation of peroxymonosulfate for an efficient degradation of tetracycline and its dual-pathway mechanism. PROCESS SAFETY AND ENVIRONMENTAL PROTECTION, 182 (416). [10.1016/j.psep.2023.11.066] |
| 2. Jiezhou Pan, Haotian Liao, Guidong Gong, Yunxiang He, Qin Wang, Lang Qin, Yaoyao Zhang, Hirotaka Ejima, Blaise L. Tardy, Joseph J. Richardson, Jiaojiao Shang, Orlando J. Rojas, Yong Zeng, Junling Guo. (2023) Supramolecular nanoarchitectonics of phenolic-based nanofiller for controlled diffusion of versatile drugs in hydrogels. JOURNAL OF CONTROLLED RELEASE, 360 (433). [PMID:37422124] [10.1016/j.jconrel.2023.07.003] |
| 3. Li Chen, Tahir Maqbool, Ghazanfar Nazir, Congyu Hou, Yanna Xu, Yulong Yang, Xihui Zhang. (2023) Peroxymonosulfate activated by composite ceramic membrane for the removal of pharmaceuticals and personal care products (PPCPs) mixture: Insights of catalytic and noncatalytic oxidation. WATER RESEARCH, 229 (119444). [PMID:36470049] [10.1016/j.watres.2022.119444] |
| 4. Lin Wang, Qiya Sun, Yicheng Dou, Zhipeng Zhang, Tingting Yan, Yongmei Li. (2021) Fabricating a novel ternary recyclable Fe3O4/graphene/sulfur-doped g-C3N4 composite catalyst for enhanced removal of ranitidine under visible-light irradiation and reducing of its N-nitrosodimethylamine formation potential. JOURNAL OF HAZARDOUS MATERIALS, 413 (125288). [PMID:33588334] [10.1016/j.jhazmat.2021.125288] |
| 5. Yan Xu, Weitao Yang, Zhuoyao Wu, Hui Wang, Tianming Cui, Weiwei Zeng, Yanjing Yun, Bingbo Zhang. (2024) A Chromium-Based magnetic resonance probe for in situ gastric pH imaging. CHEMICAL ENGINEERING JOURNAL, (154269). [10.1016/j.cej.2024.154269] |
| 6. Guodong Shan, Xiuqin Fan, Qingcheng Wang, Li Zhang, Lijun Ge, Weibo Lu, Jing Xue, Kang Chen, Zejun Wang, Qing Shen. (2025) Development of a Captiva EMR-lipid clean-up and LC-MS/MS methodology for detecting H2 receptor antagonists in functional foods and food-medicine homology materials. Applied Food Research, 5 (100772). [10.1016/j.afres.2025.100772] |
| 7. Yun-fei Zhang, Xin Quan, Sheng-gui Chen, Jian-hui Xu, Dan Li, Lei Li, Si-hao Lv, Jin-ze Li, Yi-hang Zhang, Zhuo-wei Zhong. (2025) Efficient ranitidine removal using Si3N4-ZVI/PAA system: Mechanistic insights and environmental implications. Journal of Water Process Engineering, 69 (106641). [10.1016/j.jwpe.2024.106641] |
| 8. Shi Zhengzheng, Li Jia, Pan Yupeng, Li Xuewei, Zhuang Zile, Li Yihan, Zhang Zheng, Wang Zirui, Luo Qizhi, Chen Xuncai. (2025) Fe-MOF nanoparticles supported with carbon-defective g-C3N4 nanosheet as visible-light driven photo-Fenton catalyst for efficient degradation of tetracycline hydrochloride. Emergent Materials, (1-19). [10.1007/s42247-025-01071-2] |
| 9. Fazal Muhammad Khoso, Jin-Gang Yu. (2025) Selective removal of Cd2+ from aqueous solution using a novel Ranitidine functionalized three-dimensional graphene oxide (3D RN-GO) composite: Kinetics, isotherms, thermodynamics, and regeneration studies. INORGANIC CHEMISTRY COMMUNICATIONS, 176 (114260). [10.1016/j.inoche.2025.114260] |